OXBDF - Oxford Biomedica plc GAAP EPS of 0.00p revenue of £64.03M
- Oxford Biomedica press release ( OTCPK:OXBDF ): 1H GAAP EPS of 0.00p.
- Revenue of £64.03M (-21.2% Y/Y).
- Operating EBITDA loss and operating loss of £5.8M and £19.2M respectively.
- Cash at 30 June 2022 was £118.5M and £115.8M at 31 August 2022; net cash at 30 June 2022 was £50.1M and £42.1M at 31 August 2022.
For further details see:
Oxford Biomedica plc GAAP EPS of 0.00p, revenue of £64.03M